Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)
CUSIP: 471871202
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Voting Common Stock, par value $0.0001 per share
- Total 13F shares
- 11,986,564
- Total 13F value
- $5,044,629
- Share change
- -3,767,111
- Put/Call ratio
- 11%
- SEC-reported price per share
- $0.42
- Number of holders
- 42
- Value change
- -$2,319,968
- Number of buys
- 12
- Number of sells
- 29
- Shares outstanding
- 33,973,202
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
42
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
T. Rowe Price Investment ...
Disclosed value leader
Velan Capital Investment ...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.1%
13D/G row: T. Rowe Price Investment Management, Inc.
Showing 1-6 of 15 holder rows.
Quick read
T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 7.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.
Comparable ownership
Top 5
T. Rowe Price Investment Manageme...
7.1%
ACORN BIOVENTURES, L.P.
5.3%
MORGAN STANLEY
4.8%
KINGDON CAPITAL MANAGEMENT, L.L.C.
4.7%
Carlyle Group Inc.
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. |
13D/G
|
7.1%
|
$4,897,117
2,057,612 shares
|
$0 | 30 Sep 2025 |
| ACORN BIOVENTURES, L.P. |
13D/G
Anders Hove
|
5.3%
|
$2,660,821
1,486,492 shares
|
-$537,000 | 23 Jan 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
4.8%
|
$1,226,746
1,333,420 shares
|
-$585,456 | 31 Mar 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13D/G
13F
Company
|
4.7%
|
$3,153,131
1,324,845 shares
|
+$1,332,431 | 30 Sep 2025 |
| Carlyle Group Inc. |
3/4/5
13D/G
13F
Former 10% Owner · The Carlyle Group Inc. · Company
|
3.8%
from 13D/G
|
$13,807,148
1,066,189 shares
|
— | 08 Feb 2024 |
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
13D/G
10%+ Owner
|
3.3%
from 13D/G
|
$5,525,844
8,519,648 shares
|
— | 27 Jan 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
11,986,564
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
57
Q2 2026 holders
42
Holder diff
-15
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|